Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry|May 3, 2016
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonistsDietmar Weichert, Markus Stanek, Harald Hübner, et al.Journal of Medicinal Chemistry|March 4, 2015
Molecular determinants of biased agonism at the dopamine D₂ receptorDietmar Weichert, Ashutosh Banerjee, Christine Hiller, et al.ACS Chemical Biology|April 11, 2015
Covalent molecular probes for class A G protein-coupled receptors: advances and applicationsDietmar Weichert, Peter GmeinerProceedings of the National Academy of Sciences of the United States of America|July 10, 2014
Covalent agonists for studying G protein-coupled receptor activationDietmar Weichert, Andrew C Kruse, Aashish Manglik, et al.Archiv Der Pharmazie|June 14, 2005
Chirospecific and subtype selective dopamine receptor binding of heterocyclic methoxynaphthamide analogsLaura Bettinetti, Harald Hübner, Peter GmeinerJournal of Medicinal Chemistry|May 24, 2011
Bivalent dopamine D2 receptor ligands: synthesis and binding propertiesJulia Kühhorn, Harald Hübner, Peter GmeinerJournal of Medicinal Chemistry|October 8, 2009
1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligandsDaniela Huber, Harald Hübner, Peter GmeinerBioorganic & Medicinal Chemistry Letters|August 6, 2002
Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725Stefan Löber, Harald Hübner, Peter GmeinerBioorganic & Medicinal Chemistry Letters|March 6, 2003
Cyclic amidines as benzamide bioisosteres: EPC synthesis and SAR studies leading to the selective dopamine D4 receptor agonist FAUC 312Jürgen Einsiedel, Harald Hübner, Peter GmeinerBioorganic & Medicinal Chemistry Letters|March 28, 2006
Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtypeStefan Löber, Harald Hübner, Peter GmeinerPageof 26